Literature DB >> 6344335

Lack of mutagenic activity of dimethylformamide.

J L Antoine, J Arany, A Léonard, J Henrotte, G Jenar-Dubuisson, G Decat.   

Abstract

Different test systems have been utilized to evaluate the mutagenic and carcinogenic properties of dimethylformamide (DMF), an aliphatic amide used as a solvent in chemical industry. The Ames test was performed on different strains of Salmonella typhimurium, whereas the ability of DMF to induce structural aberrations in eukaryotic chromosomes was tested by in vitro observations on human lymphocytes and in vivo experiments on mouse bone marrow. Furthermore, male mice were treated with DMF for the induction of sperm abnormalities. The negative results obtained in all test systems as well as the absence of positive reports in man or in experimental animals with respect to induction of cancers suggest strongly that DMF is devoid of mutagenic or carcinogenic properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344335     DOI: 10.1016/0300-483x(83)90082-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  Occupational dimethylformamide exposure. 3. Health effects of dimethylformamide after occupational exposure at low concentrations.

Authors:  S X Cai; M Y Huang; L Q Xi; Y L Li; J B Qu; T Kawai; T Yasugi; K Mizunuma; T Watanabe; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

2.  Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide.

Authors:  Farida Lamkarkach; Matthieu Meslin; Marike Kolossa-Gehring; Petra Apel; Robert Garnier
Journal:  Toxics       Date:  2022-05-31

3.  Increase in sister chromatid exchange rates in association with occupational exposure to N,N-dimethylformamide.

Authors:  K Seiji; O Inoue; S X Cai; T Kawai; T Watanabe; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.